The DOI matches its Crossref record; 464 of the 464 references it cites were found in a registry or an index.
Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape
Open accessAbstract
Nanoparticle‐based therapeutics, emerging from advances in nanotechnology, outperform traditional drug therapies by virtue of their distinct biological properties that enhance therapeutic efficacy, reduce toxicity, and enable precise targeting. Since the 1980s, the number of nanoparticle‐based pharmaceutical products has expanded considerably, capturing a significant portion of the pharmaceutical market. These systems function as therapeutic agents or as vehicles for delivering active pharmaceutical or diagnostic compounds to targeted areas. However, despite their transformative potential, the development of comprehensive and harmonized regulatory frameworks for nanomedicines remains a critical challenge. This review provides a current overview of market‐approved nanoparticle therapeutics, analyzing global regulatory strategies, including pre‐clinical testing, safety assessments, manufacturing processes, and quality control standards. By discussing the existing shortcomings, this review highlights the importance of adaptive regulatory pathways in a global context. It aims to support researchers and stakeholders in navigating the regulatory landscape, facilitating the successful commercialization and clinical translation of nanoparticle‐based therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 401–464 of 464
Wynn, D. R. (2019) · Multiple Sclerosis International · doi:10.1155/2019/7151685 · Cited by 33
Design, Synthetic Strategies, and Therapeutic Applications of Heterofunctional Glycodendrimers
Mousavifar, L., & Roy, R. (2021) · Molecules · doi:10.3390/molecules26092428 · Cited by 33
Casein nanoformulations - Potential biomaterials in theranostics
Khatun, S., Appidi, T., & Rengan, A. K. (2022) · Food Bioscience · doi:10.1016/j.fbio.2022.102200 · Cited by 31
Yang, X., Zhong, Z., & Huang, Y. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.05.014 · Cited by 30
Mariyam, M., Ghosal, K., Thomas, S., Kalarikkal, N., & Latha, M. S. (2017) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557517666170512095151 · Cited by 30
Glisovic, S. M., Pešić, D., Stojiljković, E., Golubović, T., Krstic, D. S., Prascevic, M. R., & Janković, Ž. (2017) · International Journal of Environmental Science and Technology · doi:10.1007/s13762-017-1367-2 · Cited by 30
Fabrication and Characterization of Hybrid Stealth Liposomes
Mineart, K. P., Venkataraman, S., Yang, Y. Y., Hedrick, J. L., & Prabhu, V. M. (2018) · Macromolecules · doi:10.1021/acs.macromol.8b00361 · Cited by 30
Refining the Design of Diblock Elastin-Like Polypeptides for Self-Assembly into Nanoparticles
Dai, M., Georgilis, E., Goudounet, G., Garbay, B., Pille, J., van Hest, J. C. M., Schultze, X., Garanger, É., & Lecommandoux, S. (2021) · Polymers · doi:10.3390/polym13091470 · Cited by 30
Lombardo, S. M., Günday-Türeli, N., Koch, M., Schneider, M., & Türeli, A. E. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121215 · Cited by 30
On Enrichment Strategies for Biomarker Stratified Clinical Trials
Wang, X., Zhou, J., Wang, T., & George, S. L. (2017) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2017.1379532 · Cited by 29
Wu, Q., Zhang, Q., Yu, T., Wang, X., Jia, C., Zhao, Z., & Zhao, J. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c00079 · Cited by 29
High-throughput single-cell analysis of nanoparticle-cell interactions
Haddad, M., Frickenstein, A. N., & Wilhelm, S. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117172 · Cited by 29
Gharib, S. A., Marignier, J., Omar, A. K. E., Naja, A., Caër, S. L., Mostafavi, M., & Belloni, J. V. (2019) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.9b06090 · Cited by 28
Moen, M. D., & Keam, S. J. (2009) · CNS Drugs · doi:10.2165/11201140-000000000-00000 · Cited by 27
Rinaldi, M., Chiosi, F., dell’Omo, R., Romano, M. R., Parmeggiani, F., Semeraro, F., Mastropasqua, R., & Costagliola, C. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04291.x · Cited by 27
Aprepitant (EMEND): the role of substance P in nausea and vomiting.
Prommer, E. (2005) · PubMed · Cited by 27
Harada, Y., Yamamoto, T., Sakai, M., Saiki, T., Kawano, K., Maitani, Y., & Yokoyama, M. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.11.016 · Cited by 27
Rana, D., Salave, S., Jain, S., Shah, R. P., & Benival, D. M. (2022) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-022-09663-9 · Cited by 27
Self-citationAdvanced Characterization and Sample Preparation Strategies for Nanoformulations
Nadkarni, A., Rana, D., Desai, N., Benival, D. M., Joshi, V. M., Salave, S., & Khunt, D. (2024) · Journal of Nanotheranostics · doi:10.3390/jnt5030008 · Cited by 27
Self-citationRole of polymer–drug conjugates in organ-specific delivery systems
Paramjot, Khan, N. M., Kapahi, H., Kumar, S., Bhardwaj, T., Arora, S., & Mishra, N. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1016436 · Cited by 26
Perspectives on dendritic architectures and their biological applications: From core to cell
Viswanath, V., & Santhakumar, K. (2017) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2017.05.023 · Cited by 26
Invega Trinza: The First Four-Times-a-Year, Long-Acting Injectable Antipsychotic Agent.
Daghistani, N., & Rey, J. A. (2016) · PubMed Central · Cited by 25
Emerging roles and biopharmaceutical applications of milk derived exosomes
Desai, N., Gadeval, A., Kathar, U., Sengupta, P., Kalia, K., & Tekade, R. K. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102577 · Cited by 25
Self-citationPeptide Functionalised Nanocarriers for Bone Specific Delivery of PTH (1-34) in Osteoporosis
Salave, S., Rana, D., & Benival, D. M. (2021) · Current Nanomedicine · doi:10.2174/2468187312666211220112324 · Cited by 25
Self-citation“Organ-on-a-chip”-based physiologically relevant pharmacokinetic models
Tambe, V., Desai, N., Rajpoot, K., & Tekade, R. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-814425-1.00024-3 · Cited by 24
Self-citationThokagevistk, K., Coppo, C., Rey, L., Carelli, A., Díez, V., Vaselenak, S., Oliveira, L., Patel, A., Sicari, E., Ramos, T., et al. (2024) · Journal of Market Access & Health Policy · doi:10.3390/jmahp12020009 · Cited by 23
Aripiprazole Lauroxil NanoCrystal®Dispersion Technology (Aristada Initio®)
Ehret, M. J., Davis, E., Luttrell, S. E., & Clark, C. (2018) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.ehda071918 · Cited by 22
Continuous-flow synthesis of Pd@Pt core-shell nanoparticles
Hashiguchi, Y., Watanabe, F., Honma, T., Nakamura, I., Poly, S. S., Kawaguchi, T., Tsuji, T., Murayama, H., Tokunaga, M., & Fujitani, T. (2021) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2021.126607 · Cited by 21
Anabolic Peptide-Enriched Stealth Nanoliposomes for Effective Anti-Osteoporotic Therapy
Salave, S., Rana, D., Kumar, H., Kommineni, N., & Benival, D. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112417 · Cited by 21
Self-citationPeters, L., Dyer, M., Schroeder, E., & D’Souza, M. S. (2023) · Journal of Pharmacy Technology · doi:10.1177/87551225231153541 · Cited by 20
Cost-Effectiveness of Genexol-PM for Treating Metastatic Breast Cancer
Kim, J., & Shin, S. (2010) · Journal of Breast Cancer · doi:10.4048/jbc.2010.13.1.104 · Cited by 18
Uniquely sized nanogels via crosslinking polymerization
Kusmus, D. N. M., van Veldhuisen, T. W., Khan, A., Cornelissen, J. J. L. M., & Paulusse, J. M. J. (2022) · RSC Advances · doi:10.1039/d2ra04123e · Cited by 18
Hori, H., Ueda, N., Yoshimura, R., Yamamoto, H., Wani, K., Etoh, Y., Haraga, K., Kitahara, J., & Nakamura, J. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970903166312 · Cited by 17
Opportunities for Collaboration at the Interface of Pharmacovigilance and Manufacturing
Beninger, P. R. (2017) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.03.010 · Cited by 17
Yadava, S. K., Basu, S. M., Chauhan, M. K., Sharma, K., Pradhan, A., Remya, V., & Giri, J. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.110927 · Cited by 17
Rajani, C., Borisa, P., Bagul, S., Shukla, K. P., Tambe, V., Desai, N., & Tekade, R. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-98367-9.00017-2 · Cited by 17
Self-citationDesai, N., Pande, S., Gholap, A. D., Rana, D., Salave, S., & Vora, L. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18564-9.00008-4 · Cited by 17
Self-citationGarnock-Jones, K. P. (2016) · Drugs · doi:10.1007/s40265-016-0627-7 · Cited by 16
Effect of surfactant on the preparation and characterization of gemcitabine-loaded particles
Lim, J.-H., Na, Y., Lee, H.-K., Kim, S., Lee, H.-J., Bang, K.-H., Wang, M., Pyo, Y.-C., Huh, H. W., & Cho, C. (2018) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-018-0402-8 · Cited by 16
How does regulatory uncertainty shape the innovation process? Evidence from the case of nanomedicine
Kwon, S., Youtie, J., Porter, A. L., & Newman, N. C. (2022) · The Journal of Technology Transfer · doi:10.1007/s10961-022-09980-8 · Cited by 16
Solid Lipid Nanoparticles in Tuberculosis
Rana, D., Salave, S., Patel, R. P., Khunt, D., Misra, M., Prajapati, B. G., Patel, G. K., & Patel, J. K. (2023) · Springer eBooks · doi:10.1007/978-3-031-14100-3_6 · Cited by 15
Self-citationCritical Design Strategies Supporting Optimized Drug Release from Polymer–Drug Conjugates
Đorđević, S., Medel, M., Hillaert, J., Masiá, E., Conejos‐Sánchez, I., & Vicent, M. J. (2023) · Small · doi:10.1002/smll.202303157 · Cited by 15
Eligard®: Advantages for Optimal Testosterone Control
TOMBAL, B. F., & Berges, R. R. (2006) · European Urology Supplements · doi:10.1016/j.eursup.2006.08.007 · Cited by 12
Lamboley-Gilmert, G., & Lacaze‐Masmonteil, T. (2003) · Pediatric Drugs · doi:10.2165/00148581-200305090-00006 · Cited by 11
Production of lipophilic nanogels by spontaneous emulsification
Ding, S., Mustafa, B., Anton, N., Serra, C. A., Chan‐Seng, D., & Vandamme, T. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119481 · Cited by 11
Synthetic strategies in construction of organic macromolecular carrier–drug conjugates
Skwarecki, A. S., Nowak, M. G., & Milewska, M. J. (2020) · Organic & Biomolecular Chemistry · doi:10.1039/d0ob01101k · Cited by 11
Hammerschmidt, S. I., Thurm, C., Bošnjak, B., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202149645 · Cited by 11
Lv, Y. B., Chandrasekharan, P., Li, Y., Liu, X., Avila, J. P., Yang, Y., Chuang, K., Liang, X., & Ding, J. (2018) · Journal of Materials Chemistry B · doi:10.1039/c7tb03129g · Cited by 10
Cross-Linking Method-Based Nanogels for Biomedical Applications
Ghobashy, M. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-36268-3_199 · Cited by 10
Process analytics for the manufacturing of nanomedicines: Challenges and opportunities
Aguiam, N., Moura, L. I. F., Oliveira, M. I. L. L., Florindo, H. F., & Lopes, J. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91819-0.00007-5 · Cited by 10
Polymer nanogels: Fabrication, structural behavior, and biological applications
Pashirova, T. N., Fernandes, A. R., Sánchez‐López, E., García, M. L., Silva, A. M., Zakharova, L. Y., & Souto, E. B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820466-5.00005-3 · Cited by 9
Carbon Nanotubes and Their Composites: From Synthesis to Applications
Vaka, M., Walvekar, R., & Swarnalatha, Y. (2020) · Engineering materials · doi:10.1007/978-3-030-62761-4_3 · Cited by 9
Nanomedicine: a socio-technical system
Massaro, S., & Lorenzoni, G. G. (2021) · Technological Forecasting and Social Change · doi:10.1016/j.techfore.2021.121066 · Cited by 9
Harrison, N. J., & Simpson, H. (2021) · Springer eBooks · doi:10.1007/978-3-030-69186-8_15 · Cited by 9
Engineered liposomes as drug delivery and imaging agents
Behera, A., Padhi, S., & Nayak, A. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89953-6.00010-6 · Cited by 8
Choi, J. W., Bae, S.-H., Kim, I. Y., Kwak, M., Lee, T. G., & Heo, M. B. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.18.436024 · Cited by 7
Chowdhury, R., & Ellis, P. (2014) · doi:10.1002/9783527682423.ch72 · Cited by 6
Khan, F. A. (2023) · Springer eBooks · doi:10.1007/978-981-99-6940-1_7 · Cited by 6
Taboada, P., Barbosa, S., Concheiro, Á., & Alvarez‐Lorenzo, C. (2014) · Royal Society of Chemistry eBooks · doi:10.1039/9781782625216-00157 · Cited by 5
Confidentiality and Privacy in Digital Clinical Trials
Aizenberg, M., & Brandolini, A. (2023) · Collaborative bioethics · doi:10.1007/978-3-031-29455-6_11 · Cited by 5
Decoding Artificial Intelligence in Neuroscience: Applications Beyond Diagnosis
Salave, S., Rana, D., Benival, D. M., & Jain, A. (2023) · Current Indian Science · doi:10.2174/2210299x01666230223104508 · Cited by 4
Self-citationGuide to Pharmaceutical Product Quality
Merkus, H. G. (2018) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-94174-5_2 · Cited by 3
Nanocarriers for Delivery of Peptide Antibiotics
Karunakaran, B., Vitore, J. G., Sharma, A. K., Rana, D., & Benival, D. M. (2023) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-031-39020-3_1 · Cited by 3
Self-citationDas, A., Deka, D., Abrar, S. S., Pathak, S., & Banerjee, A. (2021) · Springer eBooks · doi:10.1007/978-981-15-7564-8_9 · Cited by 2
Metadata
- Authors
- Desai, N., Rana, D., Patel, M., Bajwa, N., Prasad, R., & Vora, L. K.
- Venue
- Small
- Publisher
- Wiley
- Published
- 2025-06-02
- Volume
- 21
- Issue
- 29
- Pages
- e2502315-e2502315
- ISSN
- 1613-6810 (ISSN-L)
- 1613-6829
- OpenAlex
- W4410958240
- Cited by
- 295
- References
- 464
- FWCI
- 54.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.